Mylan (NASDAQ:MYL) reported second quarter earnings that beat analysts' expectations on Monday and revenue that topped forecasts.
The firm reported earnings per share of $1.03 on revenue of $2.85B. Analysts polled by forecast EPS of $0.94 on revenue of $2.81B. That compared to EPS of $1.07 on revenue of $2.81B in the same period a year earlier. The company had reported EPS of $0.82 on revenue of $2.5B in the previous quarter.
Mylan shares gained 12.54% to trade at $20.77 in intra-day trade following the report.
Mylan follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on April 30, with first quarter EPS of $0.85 on revenue of $13.12B. analysts expected EPS of $0.75 on revenue of $12.99B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
